Title : Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2.

Pub. Date : 2016 May 31

PMID : 27083050






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2. Cisplatin BCL2 apoptosis regulator Homo sapiens
2 Bcl-2 de-targeted by E6-mediated miR- 184 reduction was responsible for cisplatin resistance. Cisplatin BCL2 apoptosis regulator Homo sapiens
3 Patients with low-mR-184, E6-positive, high-Bcl-2 tumors, and both combinations were more prevalently occurred unfavorable response to cisplatin-based chemotherapy than their counterparts. Cisplatin BCL2 apoptosis regulator Homo sapiens
4 In conclusion, a decrease in miR-184 level by E6 oncoprotein may predict unfavorable response to cisplatin-based chemotherapy in HPV-infected NSCLC patients via increasing Bcl-2 expression. Cisplatin BCL2 apoptosis regulator Homo sapiens